Clinical Cancer Drugs
Published by Bentham Science Publishers
ISSN : 2212-697X eISSN : 2212-6988
Abbreviation : Clin. Cancer Drug
Aims & Scope
Clinical Cancer Drugs publishes original research and (as well as) expert reviews, and thematic issues in all core areas of translational and clinical cancer drug research.
The journal publishes pre-clinical and clinical studies on the development of new anti-cancer agents.
Clinical studies of new reported anti-cancer drugs include Phase 1–IV clinical trial studies, their designs, research methodologies, and analyses.
The journal is essential reading to clinical oncologists, toxicologists, medicinal chemists, and to pharmacologists.
View Aims & ScopeAbstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
Emerging Role and Targeting of Carcinoembryonic Antigen-related Cell Adhesion Molecule 6 (CEACAM6) in Human Malignancies
Citation: 54
Authors: Benny, Daruka
-
Arsenic-exposed Keratinocytes Exhibit Differential microRNAs Expression Profile; Potential Implication of miR-21, miR-200a and miR-141 in Melanoma Pathway
Citation: 38
Authors: Horacio, Carolina, Robert, Rosa, Armando, Renato
-
Novel Antibody Therapeutics Targeting Mesothelin In Solid Tumors
Citation: 32
Authors: Xiao-Yan, Babu, Nenad, Sven, Harald
-
Upfront DPD Deficiency Detection to Secure 5-FU Administration: Part 2- Application to Head-and-Neck Cancer Patients
Citation: 24
Authors: Manon, Joseph, Claire, Carmello, Charlotte, Nicolas, Florence, Sebastien, Bruno
-
Tumor-selective Cytotoxicity of a Novel Pentadiene Analogue on Human Leukemia/lymphoma Cells
Citation: 22
Authors: Yahaira, Umashankar, Armando, Sarah, Yoshira, Carolina, Swagatika, Alaa, Jonathan, Renato
-
Transforming Mutations of Jak3 (A573V and M511I) Show Differential Sensitivity to Selective Jak3 Inhibitors
Citation: 19
Authors: G., Jeremy, Robert
-
Inhibition of ERN1 Signaling is Important for the Suppression of Tumor Growth
Citation: 15
Authors: Oleksandr H., Dariia O., Olena O., Dmytro O.
-
The Antimalarial Drug Pyronaridine Inhibits Topoisomerase II in Breast Cancer Cells and Hinders Tumor Progression In Vivo
Citation: 13
Authors: Paulina J., Denisse A, Lisett, Karla, Aldo, Armando, Renato J
-
Arachidonic Acid Induces the Migration of MDA-MB-231 Cells by Activating Raft-associated Leukotriene B4 Receptors
Citation: 11
Authors: Atasi, Debarshi, Priscilla, Rituraj, Mahesh, Sukla, Siddhartha